Skip to Content
Merck
All Photos(1)

Documents

Safety Information

SML2641

Sigma-Aldrich

Methenamine hippurate

≥95% (HPLC)

Synonym(s):

Hexamethylenetetramine monohippurate, 1,3,5,7-Tetraazatricyclo[3.3.1.13,7]decane N-Benzoylglycine, Hippuric acid, compd. with hexamethylenetetramine (1:1)

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C6H12N4 · C9H9NO3
CAS Number:
5714-73-8
Molecular Weight:
319.36
MDL number:
MFCD00072147
UNSPSC Code:
12352116
NACRES:
NA.77

Assay

≥95% (HPLC)

form

powder

storage condition

desiccated

color

white to beige

solubility

H2O: 2 mg/mL, clear

storage temp.

2-8°C

SMILES string

OC(CNC(C1=CC=CC=C1)=O)=O.N2(CN(C3)C4)CN3CN4C2

InChI

1S/C9H9NO3.C6H12N4/c11-8(12)6-10-9(13)7-4-2-1-3-5-7;1-7-2-9-4-8(1)5-10(3-7)6-9/h1-5H,6H2,(H,10,13)(H,11,12);1-6H2

InChI key

ROAIXOJGRFKICW-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Biochem/physiol Actions

Methenamine hippurate is a broad-spectrum urinary tract antiseptic drug. The methenamine component is hydrolyzed to formaldehyde in acid urine. Hippuric acid acts to keep the urine acid.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

JAN Code

SML2641-BULK:
SML2641-250MG:
SML2641-100MG:
SML2641-VAR:

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Cathy Davis et al.
British journal of nursing (Mark Allen Publishing), 26(9), S12-S19 (2017-05-12)
In her lifetime, a woman is highly likely to develop at least one lower urinary tract infection. Early detection and treatment are key. Being aware of predisposing factors for infection and understanding appropriate diagnosis and treatment regimens will help nurses
Tze Shien Lo et al.
Expert review of anti-infective therapy, 12(5), 549-554 (2014-04-03)
In the era of multidrug resistance, it is critical to utilize antibiotics in an appropriate manner and to identify new treatments or revisit the use of 'forgotten' drugs. Because urinary tract infections (UTIs) are common, particularly in an increasing elderly
Maria E Terlizzi et al.
Frontiers in microbiology, 8, 1566-1566 (2017-09-02)
Urinary tract infections (UTIs) are one of the most common pathological conditions in both community and hospital settings. It has been estimated that about 150 million people worldwide develop UTI each year, with high social costs in terms of hospitalizations

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service